Lower trabecular bone score is associated with an increased incidence of localized femoral periosteal thickening

• Published in: Journal of bone and mineral metabolism 2021-11, Vol.39 (6), p.952-961
• Main Authors: Sato, Hiroe, Kondo, Naoki, Kurosawa, Yoichi, Hasegawa, Eriko, Wakamatsu, Ayako, Kobayashi, Daisuke, Nakatsue, Takeshi, Kazama, Junichiro James, Kuroda, Takeshi, Suzuki, Yoshiki, Endo, Naoto, Narita, Ichiei
• Format: Article
• Language: English
• Subjects: Autoimmune diseases; Body mass index; Bone mineral density; Cancellous bone; Dual energy X-ray absorptiometry; Femur; Fractures; Glucocorticoids; Medicine; Medicine & Public Health; Metabolic Diseases; Multivariate analysis; Original Article; Orthopedics; Prednisolone; Risk factors; Vertebrae; X-rays
• ISSN: 0914-8779; 1435-5604
• DOI: 10.1007/s00774-021-01244-z

Introduction Femoral localized periosteal thickening (LPT, also termed “beaking”) of the lateral cortex often precedes an atypical femoral fracture (AFF). Bisphosphonate (BP) use, glucocorticoid use, and Asian race are major risk factors for developing such fractures. The aim of this study was to determine whether the trabecular bone score (TBS) reflecting the lumbar trabecular microarchitecture was related to LPT in glucocorticoid-treated Japanese patients with autoimmune diseases. Materials and methods We retrospectively investigated 111 women with autoimmune diseases treated with prednisolone (PSL) who had undergone both femoral X-ray and dual-energy X-ray absorptiometry of the L1 − L4 lumbar vertebrae and for whom TBS could be evaluated for two or more of these. Results Femoral LPT was evident in the X-rays of 18 of 111 patients (16.2%). Higher body mass index (BMI), longer duration of PSL use and longer duration of BP use were significant in patients with LPT compared to those without. The TBS was significantly lower in patients with LPT than in those without (1.314 ± 0.092 vs. 1.365 ± 0.100, p  = 0.044); however, the lumbar bone mineral density did not differ significantly (0.892 ± 0.141 vs. 0.897 ± 0.154 g/cm 2 , p  = 0.897). TBS was significantly associated with LPT (odds ratio, 0.004; 95% CI, 0 − 0.96; p  = 0.048), but not in the multivariate analysis including BMI, duration of PSL use and duration of BP use. Conclusions The TBS was lower in glucocorticoid-treated Japanese women with autoimmune diseases with LPT than in those without LPT, and deteriorated trabecular microarchitecture influenced by longer use of BP and glucocorticoid might be associated with the development of LPT.